Ceph Lifesciences completed the acquisition of the active pharmaceutical ingredients and formulations business of Nectar Lifesciences for INR12.7bn.

Ceph Lifesciences, a pharmaceutical company, completed the acquisition of the active pharmaceutical ingredients and formulations business of Nectar Lifesciences, a pharmaceutical company, for INR12.7bn. “This transaction marks a significant milestone in Nectar Lifesciences’ evolution. By divesting mature segments of our business, we are laying the foundation for a focused and agile organization geared towards innovation and long-term value creation. We thank our stakeholders for their continued trust and support as we embark on this next chapter,” Sanjiv Goyal, Nectar Lifesciences Promoter and Chairman.